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To determine the inﬂuence of smoking on blood and salivary superoxide dismutase enzyme levels among
smokers, and to demonstrate the signiﬁcant alterations in the levels of superoxide dismutase in asso-
ciation with patient age, periodontal disease status, smoking duration, and smoking frequency. This
study also aimed to evaluate the use of saliva as a biological ﬂuid for disease diagnosis.
Ninety males aged 25e56 years were selected and included 30 smokers, 30 nonsmokers with chronic
periodontitis, and 30 healthy controls. Clinical parameters such as the gingival index, pocket depth, and
clinical attachment loss were recorded. Blood and saliva samples were collected and superoxide dis-
mutase enzyme levels were analyzed using spectrophotometric assay.
Superoxide dismutase enzyme levels in the blood and saliva were signiﬁcantly higher in smokers than
in nonsmokers and the controls (p < 0.05). A signiﬁcant correlation existed between superoxide dis-
mutase levels and clinical parameters. There was also a signiﬁcant positive correlation between blood
and salivary superoxide dismutase levels among the three groups.
Systemic and local antioxidant status is affected by periodontal disease and by the impact of smoking.
The increased blood and salivary superoxide dismutase enzyme levels in smokers may be an adaptive
defense mechanism to counteract the increased reactive oxygen species production induced by smoking.
This study emphasizes the importance of saliva as an easy noninvasive tool in diagnosing patients who
are more prone to precancerous lesions and conditions, and its importance in patient education and
motivation programs for smoking cessation.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Most periodontal tissue destruction is caused by an inappro-
priate host response to microorganisms and their products. To be
more speciﬁc, a loss of homeostatic balance between proteolytic
enzymes (e.g., neutrophil elastase) and their inhibitors (e.g., a1
antitrypsin) and between reactive oxygen species (ROS) and theics, Yenepoya Dental College
, Mangalore, India.
ifer).
for Food and Biomolecules,
molecules, National Taiwan Univeantioxidant defense systems that protect and repair vital tissue and
cellular and molecular components are believed to be responsible.1
Polymorphonuclear leukocytes (PMNLs) are a particularly rich
source of ROS, which in the absence of suitable antioxidants can
lead to tissue damage. Stimulation by bacterial antigens causes
PMNLs to produce superoxide (O2$) via the metabolic pathway of
the “respiratory burst” during phagocytosis. Inﬂammatory cells
such as ﬁbroblasts, vascular endothelial cells, and osteoclasts also
produce ROS. They are highly toxic to the ingested microorganisms
and to the host cells.2,3
Because cigarette smoke contains a large amount of oxidative
species, smoking increases ROS production and is a signiﬁcant
source of oxidative stress. Smokers are nearly four times more
likely than nonsmokers to have severe periodontitis.4rsity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
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the detrimental effects of ROS in vivo. An antioxidant may be
regarded as any substance that, whenpresent in lowconcentrations
(compared to the concentration of an oxidizable substrate), signif-
icantly delays or inhibits the oxidation of that substrate.2 The hu-
man body has an array of nonenzymatic and enzymatic antioxidant
(AO) defense mechanisms to remove harmful ROS and to prevent
their deleterious effects. The nonenzymatic antioxidants include
vitamins A, C, and E; uric acid; bilirubin; reduced glutathione; al-
bumin; transferrin; lactoferrin; ceruloplasmin; and haptoglobin.
The enzymatic antioxidants include superoxide dismutase (SOD),
glutathione peroxidase (GSH-Px), and catalase (CAT).2,5 A delicate
balance exists between antioxidant defense repair systems and pro-
oxidantmechanismsof tissue destruction; if the balance is shifted in
favor of ROS activity, signiﬁcant tissue damage ensues.6
Within mammalian tissues, the most signiﬁcant antioxidant is
SOD, which catalyses the dismutation of superoxide (O2·), an oxy-
gen radical that is released in inﬂammatory pathways and causes
connective tissue breakdown. This enzyme is released as a ho-
meostatic mechanism to protect the tissues. It can be detected in
extra- and intracellular compartments. Superoxide dismutase has
been localized in the human periodontal ligament, and it may
represent an important defense within gingival ﬁbroblasts against
superoxide release.3
Superoxide dismutase, previously known as erythrocuprein (in
humans) or hemocuprein (in bovines), exists as a family of metal-
loproteins and is widely distributed in mammalian tissues. Eryth-
rocytes only contain the copper/zinc SOD isoenzyme, which is
coded by a gene located on chromosome 21. By virtue of their
physiological role, erythrocytes are exposed to continuous oxida-
tive stress because oxygen radicals are continuously generated by
autoxidation of hemoglobin.7
Saliva, in addition to its lubricant properties, contains many
biochemical substances, antibacterial components, and various
antioxidants. It therefore could constitute a ﬁrst line of defense
against free radical-mediated oxidative stress.
Free radical scavenging and the antioxidant defense system have
an important role in maintaining normal cellular physiology, facing
diseases, and promoting immunity.8 There are sparse previous
studies that considered the effects of smoking on the antioxidant
status of blood and salivawith regard to periodontal conditions, and
have yielded conﬂicting results.3,5,9 Hence, the present study was
performed to evaluate the inﬂuence of smoking on periodontal
health byestimating the SOD enzyme level in the blood and saliva of
smokers and nonsmokers with chronic periodontitis. The enzyme
levels in blood and saliva among healthy, smokers and nonsmokers
were also compared and correlated with clinical ﬁndings.
2. Materials and methods
Ninety male participants in the age range of 25e56 years were
selected by random sampling from the outpatient Department of
Periodontics, P.M. Nadagouda Memorial Dental College and Hos-
pital (Bagalkot, Karnataka, India). They were divided into three
categories, based on the clinical periodontal parameters, smoking
status, and inclusion criteria: Group I comprised 30 healthy in-
dividuals with no clinical and radiographic manifestations of
periodontal disease; Group II comprised 30 nonsmokers with
chronic periodontitis and at least 20 natural teeth and a minimum
of six periodontal pockets ≥5 mm or the loss of attachment of
3 mm10; and Group III comprised 30 smokers (based on the self-
reported smoking status) with chronic periodontitis. Current
smokers who smoked 10 cigarettes per day and who fulﬁlled the
criteria of chronic periodontitis were enrolled in the study.3,11 All
included participants were systemically healthy; had no history ofantibiotic, anti-inﬂammatory, or antioxidant drug treatment within
the previous 6 months; and had not undergone periodontal treat-
ment for at least 6 months prior to sampling and recording.
Females; individuals with systemic diseases such as diabetes
mellitus, hepatitis, rheumatoid arthritis, cardiovascular disease,
and human immunodeﬁciency virus infection; and regular users of
vitamin supplements were excluded from the study. The need and
design of the study were explained to all potential participants.
Only those who gave written informed consent were included in
the study. Ethical clearance for the study was obtained from the
ethical committee of P.M. Nadagouda Memorial Dental College and
Hospital in Bagalkot.
The gingival index (Loe and Silness),12 probing pocket depth
(PD),13,14 and clinical attachment loss (CAL)13,14 were assessed.
Blood and saliva samples were collected from all participants 48
hours after the clinical measurements in the morning after an
overnight fast. The study participants were asked not to eat or drink
(except water) prior to sample collection.
2.1. Collection of saliva samples
Unstimulated whole saliva samples were used in this study.
After rinsing the mouth with 15 mL of plain water to remove
exfoliated cells and debris, the participants were asked to allow
saliva to pool in the bottom of the mouth and spit it on to ice chilled
sterile polypropylene tubes. Approximately 1 mL of whole saliva
was collected and centrifuged immediately at 3000 g at 4 C for 5
minutes. The resultant supernatant was aspirated and assayed
biochemically for the estimation of the SOD enzyme level.15
2.2. Collection of blood samples
Two milliliters of venous blood was drawn from the antecubital
vein of all participants by using a disposable syringe. It was trans-
ferred to sterile vial containing the anticoagulant EDTA.
2.3. Preparation of erythrocyte lysate
The blood was centrifuged at 2000  g for 20 minutes at 25C.
The plasma and the upper layer of the red blood cell pellet, which
contains the buffy coat, were removed aseptically. The red blood
cell (RBC) pellet was washed three times with sterile saline
(0.85 gm/100 mL) to ensure complete removal of the plasma, leu-
kocytes, and platelets. Thewashed RBCs were hemolyzed by adding
sterile distilled water (1:5 by volume). The lysate was then
centrifuged at 800  g for 15 minutes at 4C to make the lysate
ghost free. The supernatant was used as the source for the SOD
enzyme estimation.16 All samples were immediately prepared and
assayed on the same day.
2.4. Estimation of SOD enzyme
The superoxide dismutase level was estimated in saliva and
erythrocytic lysate by using the method of Misra and Fridovich.17
2.5. The principle
The ability of SOD to inhibit the autoxidation of adrenaline to
adrenochrome at pH 10.2 was the basis for this assay. The super-
oxide (O2·) anion, which is the substrate for the SOD enzyme, is
generated indirectly by the oxidation of epinephrine by oxygen in
an alkaline pH. The SOD enzyme reacts with the O2· formed during
the epinephrine oxidation, and therefore slows the rate and the
amount of adrenochrome formation.
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The reagents used were the following: (1) sodium carbonate
buffer 0.1M (pH 10.2; supplied by HiMedia Laboratories Pvt. Ltd.
A-516,Swastik Disha Business Park,Via Vadhani Ind. Est., LBS Marg,
Mumbai-400086, India) and (2) epinephrine (1 mM; supplied by
Sigma-Aldrich, E 1635-5G, shanghai, China).
2.7. Procedure
The supernatant sample (1 mL) was added into test tubes con-
taining 0.5 mL of carbonate buffer (0.1M, pH 10.2). Water was
added to this mixture to a ﬁnal volume of 2.5 mL. This mixture was
pipetted into a cuvette and 0.5 mL of epinephrinewas added to it to
initiate the reaction. The reaction was monitored at 12-second in-
tervals for 1 minute at 480 nm and 25.
C using a UV-visible spectrophotometer (Beijing, China (Main-
land)). A suitable control that lacked the enzyme was run simul-
taneously. The change in the absorbance due to the inhibition of the
conversion of epinephrine to adrenochrome was measured. The
enzyme unit was calculated as the amount of the enzyme required
to inhibit the auto-oxidation of epinephrine by 50%.17
2.8. Calculations
The percentage inhibition versus the concentration of SOD
standards was plotted. Logarithmic transformation values of SOD
standards were used. The SOD levels of the unknown samples were
determined from the standard curve by using the percentage
inhibition.
The percentage inhibition was calculated by the following
formula:





One unit of SOD was deﬁned as the amount of enzyme required
to inhibit the auto-oxidation of epinephrine by 50%. The SOD levels
in erythrocytes were expressed as units/mL in the RBC suspension
and as units/mL in saliva.
2.9. Statistical evaluation
The descriptive data are expressed as the mean and standard
deviation. The statistical software [SPSS 15.0 (SPSS Inc., Chicago, IL,
USA), Stata 8.0, Medical 9.0.1 and Systat 11.0 (Chicago, USA)] were
used for the analysis. Statistical signiﬁcance was set at p < 0.05.
Comparison of clinical parameters of the three groups was analyzed
using the KruskaleWallis analysis of variance (ANOVA) test and by
one-way ANOVA test. Comparison of the blood and saliva SOD
enzyme levels among the three groups was analyzed by one-way
ANOVA test. Pair-wise comparison was performed by Tukey's
honest signiﬁcant difference (HSD) post hoc procedures. Karl
Pearson's correlation coefﬁcient was used to correlate between
blood and salivary SOD levels with clinical parameters among the
three groups. Blood and salivary SOD levels were also correlated
with each other in all three groups.Table 1
Comparison of the three groups with respect to clinical parameters.
Clinical parameters Group I (control) mean ± SD Group II (nonsmokers) m
Gingival index 0.08 ± 0.08 2.13 ± 0.52
Pocket depth 2.05 ± 0.25 5.97 ± 0.61
Clinical attachment loss 0.09 ± 0.11 5.57 ± 1.15
*Indicates 5% level of signiﬁcance (p < 0.05).
The H value is based on KruskaleWallis analysis of variance (ANOVA); the F value is bas3. Results
Themean age of the study participants was 39.77 ± 9.33 years in
Group I; 39.10 ± 9.72 years in Group II; and 38.90 ± 9.65 years in
Group III. There was no statistically signiﬁcant difference in the
mean age among the three study groups (p > 0.05).
The mean gingival index score among the smokers (1.19 ± 0.55)
was signiﬁcantly less than that of nonsmokers (2.13 ± 0.52);
whereas the mean pocket probing depth and CAL were higher in
the smokers than in the nonsmokers. All values were statistically
signiﬁcant (p < 0.05) (Table 1).
Blood SOD enzyme levels in the smoker and nonsmoker peri-
odontitis groups were higher than in the control group (Fig. 1). The
mean blood SOD value of 19.09 ± 9.89 units/mL RBC suspensions
was signiﬁcantly the highest in the smokers (Table 2). Salivary SOD
enzyme levels were signiﬁcantly higher in smokers, followed in
descending order by nonsmokers and the controls with the mean
values of 23.11 ± 8.11 U/mL saliva, 13.37 ± 6.47 U/mL saliva, and
4.73 ± 3.36 U/mL saliva, respectively (Table 3). With respect to
blood and saliva SOD levels, a pair-wise comparison between the
groups also showed signiﬁcant results.
The correlation between superoxide dismutase enzyme levels
with age and clinical parameters among the groups showed an
insigniﬁcant correlation between SOD levels and clinical parameters
in Group I; a statistically signiﬁcant positive correlation between the
CAL and the SOD levels of blood and saliva in Group II; and a sig-
niﬁcant negative correlation between themean gingival index score
and blood SOD levels in Group III. There was a positive correlation
between blood and salivary SOD with mean probing PD and CAL.
With regard to the correlation between smoking status and
clinical parameters, the number of cigarettes smoked per day and
the number of pack years showed a signiﬁcant positive correlation
with the PD and clinical attachment loss (CAL; p < 0.05). The
duration of smoking showed a positive correlation with clinical
parameters, but the value was not statistically signiﬁcant. A highly
signiﬁcant positive correlation existed between CAL and the
number of cigarettes smoked per day and the number of pack years,
as analyzed by Karl Pearson's correlation coefﬁcient method.
When blood SOD was correlated with saliva SOD, each group
showed a statistically signiﬁcant positive correlation, as evaluated
by Karl Pearson's correlation coefﬁcient method (Table 4).
4. Discussion
Smoking has long been recognized as a risk factor for peri-
odontal disease. A great deal of research into the detrimental effects
of tobacco smoking has concluded that it has widespread systemic
effects, many of which may provide mechanisms that increase an
individual's susceptibility to periodontal disease and affect their
response to treatment by stimulating destructive/inﬂammatory
responses and impairing protective/reparative responses.18 To-
bacco constituents can exacerbate aspects of the respiratory burst
and enhance ROS production.19 Superoxide dismutase is an anti-
oxidant enzyme that acts against the superoxide oxygen radical
released in inﬂammatory pathways and causes connective tissue
breakdown.20 This study attempted to estimate and compare theean ± SD Group III (smokers) mean ± SD Signiﬁcance p
1.19 ± 0.55 H value, 70.7233 0.0000*
6.82 ± 0.95 F value, 435.5330 0.0000*
6.50 ± 1.52 F value, 294.9099 0.0000*
ed on one-way ANOVA.
Fig. 1. Schematic representation of mechanism of “Respiratory burst”, leading to periodontal breakdown. Also showing elevated levels of superoxide dismutase enzyme levels
among smokers. GSH ¼ reduced glutathione; GSSG ¼ oxidized glutathione; SOD ¼ superoxide dismutase.
Table 2
Comparison of the three groupswith respect to blood superoxide dismutase enzyme
levels.
Group Mean SD
I 4.96 2.91 F ¼ 35.2838
II 10.92 4.69 p ¼ 0.0000*
III 19.09 9.89
Pair-wise comparison is by Tukey's HSD post hoc procedures
Control vs. nonsmokers 0.0020*
Control vs. smokers 0.0001*
Nonsmokers vs. smokers 0.0001*
*Indicates 5% level of signiﬁcance (p < 0.05).
HSD ¼ honest signiﬁcant difference.
Table 3
Comparison of the three groups with respect to salivary superoxide dismutase
enzyme levels.
Group Mean SD
I 4.73 3.36 F ¼ 64.0218
II 13.37 6.47 p ¼ 0.0000*
III 23.11 8.11
Pair-wise comparison by Tukey's HSD post hoc procedures
Control vs. nonsmokers 0.0001*
Control vs. smokers 0.0001*
Nonsmokers vs. smokers 0.0001*
*Indicates 5% level of signiﬁcance (p < 0.05).
HSD ¼ honest signiﬁcant difference.
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Table 4
The correlation between blood superoxide dismutase and salivary superoxide





*Indicates 5% level of signiﬁcance (p < 0.05).
r ¼ correlation coefﬁcient.
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nonsmokers with chronic periodontitis and correlate these levels
with the severity of periodontal diseases. To the best of our
knowledge, this is the ﬁrst study simultaneously evaluating the
SOD enzyme levels in blood erythrocytes and saliva of smokers and
nonsmokers with periodontitis.
In the present study, smokers were enrolled based on their self-
reported smoking status. Only current smokers, who smoked 10
cigarettes per day (i.e., heavy smokers) were included in the
study.3,11 The prevalence of female smokers in India is low (4%)3;
for this reason and to avoid the sex-inﬂuenced changes on the SOD
enzyme levels, female patients were not enrolled in the present
study.
Smokers had signiﬁcantly increased PD (6.82 ± 0.95 mm) and
CAL (6.50 ± 1.52 mm), compared to nonsmokers. However, the
gingival index was signiﬁcantly higher in nonsmokers with peri-
odontitis (2.13 ± 0.52) than in smokers (1.19 ± 0.55). This supports
the concept that smokers generally present with reduced gingival
inﬂammation and bleeding on probing, compared to nonsmokers,
because smoking has a strong, chronic, dose-dependent suppres-
sive effect on gingival inﬂammation and bleeding on probing, as
documented in the third National Health and Nutritional Exami-
nation Survey (NHANES III).11
Results showed signiﬁcantly increased SOD enzyme levels in the
blood (i.e., in erythrocytes) and saliva of smokerswith periodontitis,
compared to nonsmokers with periodontitis and healthy controls.
Variousmedical literature reports have shown that erythrocyte SOD
activities are increased in cigarette smokers, irrespective of peri-
odontal disease.21e24 It is primarily attributed to the fact that
erythrocyte antioxidants have protective effects against oxidative
damage induced by smoking. The result of our study explains the
hypothesis that an exaggerated response by erythrocytes occurs in
response to increased oxidative stress in smokers. In 2011, Russo
et al25 also stated that acute exposure to high levels of free radicals
may downregulate the gene expression of antioxidant enzymes,
whereas chronic continuous exposure may increase the gene
expression of these enzymes. Tonguc et al5 demonstrated higher
blood and gingival tissue SOD levels among the smokers with
periodontitis, compared to nonsmokers and formers smokers.
In our study, unstimulated whole saliva was used for analysis.
The salivary SOD level was signiﬁcantly higher in smokers
(23.11 ± 8.11 U/mL) than in the nonsmokers (13.37 ± 6.47 U/mL)
and the control groups (4.73 ± 3.36 U/mL). This is in accordance
with a study by Kanehira et al26 in which a comparison of salivary
antioxidant enzyme levels in elderly smokers and nonsmokers
showed a signiﬁcant increase in the SOD level among the smokers.
Studies by Nagler27 and Baharavand et al28 showed similar results.
Saliva, in addition to its cleansing and lubricating properties, con-
stitutes a ﬁrst line of defense against free radical-mediated oxida-
tive stress. Most research reports of biomarkers and periodontitis
have used Gingival Crevicular Fluid (GCF) as a sample ﬂuid. How-
ever, sampling GCF is time-consuming and only reﬂects the gingival
inﬂammation at each speciﬁc site sampled. In contrast to GCF, saliva
is abundant and sampling it is much easier, less costly, and bettertolerated by a patient. In addition, because whole saliva represents
a pooled sample with contributions from all periodontal sites, the
analysis of biomarkers in saliva may provide an overall assessment
of the disease status, as opposed to the site-speciﬁc GCF analysis.15
For analyzing the antioxidant status, whole saliva is the most
relevant because it contains gingival crevicular ﬂuid, immune cells,
and tissue metabolites, and reﬂects most closely the predominant
intraoral condition. By contrast, stimulation may increase the ﬂow
of gingival crevicular ﬂuid and this may result in false increases in
the concentration of antioxidants in saliva.4
Studies evaluating the effects of smoking on SOD activity,
regardless of periodontal status, have suggested that smoking in-
creases the SOD activity in blood and saliva.21,23,26,29,30 It has also
been reported that after smoking cessation30 and periodontal
therapy,31,32 the increased SOD activity in smokers had decreased
to the level in nonsmokers.
In contrast to our results, some studies have shown signiﬁcantly
lower activity of SOD among smokers with chronic periodontitis in
blood,16 in saliva,3 in periodontal tissues,16 and GCF3; whereas other
studies have reported no changes in blood33,34 and salivary4 anti-
oxidant capacity among smokers and nonsmokers. These studies
suggest that increased oxidative stress induced by smoking would
have resulted in the depletion and inactivation of SOD caused by
increased production of hydrogen peroxide. However, the increased
level of SOD in our study conﬁrms several ﬁndings in medical
literature on oxidanteantioxidant imbalance. The SOD activity in-
creases directly after oxidative stress. This elevation of the SOD
level in blood and saliva occurs as a protective defense mechanism
to scavenge the excessive superoxide radical produced by smoking-
induced oxidative stress.20
There was a positive correlation between the SOD values in
blood and in saliva and the gingival index, PD, and CAL in
nonsmoker patients with periodontitis. However, only CAL showed
a signiﬁcant value in blood SOD and salivary SOD (p < 0.05). This is
in agreement with the ﬁndings of other studies32,35,36 that show
that SOD activity increases with the progression of inﬂammation in
chronic periodontitis; human periodontal ligament possesses the
enzyme SOD, which may afford biological protection against ROS
(particularly superoxide) during the inﬂammatory response.37 The
increase in production of superoxide radical may have resulted in
oxidative stress, and then caused an increased need for SOD pro-
duction to establish a ROSeAO balance to protect the tissue. Kim
et al31 showed that when periodontitis is in the active state, the
immune defense mechanism is activated and PMNLs increase their
release of ROS, which results in the release of endogenous antiox-
idants in the body with a concomitant increase in the antioxidant
level in saliva.
Smoking induces a selective increase of antioxidant enzyme
activity in tissues as a self defense mechanism; this increase is
insufﬁcient to protect tissues from the direct harmful effects of
smoking.6,30,38 Excessive SOD produced as a defense mechanism
may have resulted in the overproduction of hydrogen peroxide
(H2O2) because of dismutation of the superoxide radical. The H2O2
must then be detoxiﬁed by the enzyme glutathione peroxidase
(GSH-Px). It is possible that the GSH-Px level or activity may have
been adversely affected by increased SOD level or activity after a
person is exposed to cigarette smoke.21,26 This accumulation of
undetoxiﬁed H2O2, which belongs to the ROS group, may act as a
constant source of oxidative stress and increase periodontal
destruction in smokers.
When blood SOD was correlated with salivary SOD, a signiﬁcant
positive correlationwas seen among all three groups. This indicates
that the body attempts to counteract ROS by locally and systemi-
cally increasing endogenous antioxidant enzyme activity to protect
the tissues as the oxidative stress increases.
H.D. Jenifer et al. / Journal of Traditional and Complementary Medicine 5 (2015) 100e105 105This signiﬁes that the biochemical changes occurring in blood
during the disease process occurs simultaneously in saliva. Hence,
as a future perspective, saliva can be considered as a non invasive
diagnostic ﬂuid over blood analysis in disease diagnosis.
The limitation of our present study is that the smoking status
was recorded by the self-report of the study participants. However,
the estimation by serum cotinine assay would be more reliable for
the evaluation of the smoking status of an individual. Therefore,
further studies should be considered that use serum cotinine assay
and that include individuals by severity of periodontitis.Conﬂicts of interest
All authors declare no conﬂicts of interest.References
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